Last reviewed · How we verify
Wee-1 kinase inhibitor AZD1775
Wee-1 kinase inhibitor AZD1775 is a Small molecule drug developed by AstraZeneca. It is currently in Phase 1 development.
At a glance
| Generic name | Wee-1 kinase inhibitor AZD1775 |
|---|---|
| Sponsor | AstraZeneca |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Testing AZD1775 inC Combination With Radiotherapy and Chemotherapy in Cervical, Upper Vaginal and Uterine Cancers (PHASE1)
- CISPLATIN + AZD-1775 In Breast Cancer (PHASE2)
- AZD1775 for Advanced Solid Tumors (PHASE1)
- AZD1775 Continued Access Study to Assess Safety and Tolerability for Patients Enrolled in AZD1775 Clinical Pharmacology Studies (PHASE1)
- Effects of AZD1775 on the PK Substrates for CYP3A, CYP2C19, CYP1A2 and on QT Interval in Patients With Advanced Cancer (PHASE1)
- Phase Ib Study AZD1775 in Combination With Carboplatin and Paclitaxel in Adult Asian Patients With Solid Tumours (PHASE1)
- Phase I Study to Assess the Effect of Food on AZD1775 Pharmacokinetics in Patients With Advanced Solid Tumours (PHASE1)
- Cisplatin With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Wee-1 kinase inhibitor AZD1775 CI brief — competitive landscape report
- Wee-1 kinase inhibitor AZD1775 updates RSS · CI watch RSS
- AstraZeneca portfolio CI
Frequently asked questions about Wee-1 kinase inhibitor AZD1775
What is Wee-1 kinase inhibitor AZD1775?
Wee-1 kinase inhibitor AZD1775 is a Small molecule drug developed by AstraZeneca.
Who makes Wee-1 kinase inhibitor AZD1775?
Wee-1 kinase inhibitor AZD1775 is developed by AstraZeneca (see full AstraZeneca pipeline at /company/astrazeneca).
What development phase is Wee-1 kinase inhibitor AZD1775 in?
Wee-1 kinase inhibitor AZD1775 is in Phase 1.
Related
- Manufacturer: AstraZeneca — full pipeline
- Compare: Wee-1 kinase inhibitor AZD1775 vs similar drugs
- Pricing: Wee-1 kinase inhibitor AZD1775 cost, discount & access